120 related articles for article (PubMed ID: 37850873)
1. Amide Proton Transfer-Weighted Imaging and Multiple Models Intravoxel Incoherent Motion-Based
Meng N; Jiang H; Sun J; Shen L; Wang X; Zhou Y; Wu Y; Fu F; Yuan J; Yang Y; Wang Z; Wang M
J Magn Reson Imaging; 2024 Jul; 60(1):125-135. PubMed ID: 37850873
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Amide Proton Transfer-Weighted Imaging for Lung Cancer Subtype and Epidermal Growth Factor Receptor: A Comparative Study With Diffusion and Metabolic Parameters.
Meng N; Fu F; Feng P; Li Z; Gao H; Wu Y; Zhang J; Wei W; Yuan J; Yang Y; Liu H; Cheng J; Wang M
J Magn Reson Imaging; 2022 Oct; 56(4):1118-1129. PubMed ID: 35258145
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity of amide proton transfer-weighted imaging for assessing programmed death-ligand 1 status in non-small cell lung cancer: a comparative study with intravoxel incoherent motion and
Meng N; Fu F; Sun J; Feng P; Luo Y; Wu Y; Li X; Yuan J; Yang Y; Liu H; Wang Z; Wang M
Quant Imaging Med Surg; 2022 Sep; 12(9):4474-4487. PubMed ID: 36060584
[TBL] [Abstract][Full Text] [Related]
4. Chemical Exchange Saturation Transfer MRI: Capability for Predicting Therapeutic Effect of Chemoradiotherapy on Non-Small Cell Lung Cancer Patients.
Ohno Y; Yui M; Yamamoto K; Takenaka D; Koyama H; Nagata H; Ueda T; Ikeda H; Ozawa Y; Toyama H; Yoshikawa T
J Magn Reson Imaging; 2023 Jul; 58(1):174-186. PubMed ID: 36971493
[TBL] [Abstract][Full Text] [Related]
5. A Comparative Study of Amide Proton Transfer Weighted Imaging and Intravoxel Incoherent Motion MRI Techniques Versus (18) F-FDG PET to Distinguish Solitary Pulmonary Lesions and Their Subtypes.
Fang T; Meng N; Feng P; Huang Z; Li Z; Fu F; Yuan J; Yang Y; Liu H; Roberts N; Wang M
J Magn Reson Imaging; 2022 May; 55(5):1376-1390. PubMed ID: 34723413
[TBL] [Abstract][Full Text] [Related]
6. Editorial for "Amide Proton Transfer-Weighted Imaging and Multiple Models Intravoxel Incoherent Motion Based
Chen BB; Huang YS
J Magn Reson Imaging; 2024 Jul; 60(1):136-137. PubMed ID: 37792393
[No Abstract] [Full Text] [Related]
7. Comparative Study of Amide Proton Transfer-Weighted Imaging and Intravoxel Incoherent Motion Imaging in Breast Cancer Diagnosis and Evaluation.
Meng N; Wang XJ; Sun J; Huang L; Wang Z; Wang KY; Wang J; Han DM; Wang MY
J Magn Reson Imaging; 2020 Oct; 52(4):1175-1186. PubMed ID: 32369256
[TBL] [Abstract][Full Text] [Related]
8. Amide proton transfer-weighted imaging and stretch-exponential model DWI based
Meng N; Song C; Sun J; Liu X; Shen L; Zhou Y; Dai B; Yu X; Wu Y; Yuan J; Yang Y; Wang Z; Wang M
Cancer Imaging; 2024 Mar; 24(1):33. PubMed ID: 38439101
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
10. Amide Proton Transfer-Weighted Imaging and Multiple Models Diffusion-Weighted Imaging Facilitates Preoperative Risk Stratification of Early-Stage Endometrial Carcinoma.
Meng N; Fang T; Feng P; Huang Z; Sun J; Wang X; Shang J; Wang K; Han D; Wang M
J Magn Reson Imaging; 2021 Oct; 54(4):1200-1211. PubMed ID: 33991377
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
Chen HH; Chiu NT; Su WC; Guo HR; Lee BF
Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer.
Zhang F; Wu X; Zhu J; Huang Y; Song X; Jiang L
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3250-3259. PubMed ID: 33630146
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
[TBL] [Abstract][Full Text] [Related]
14. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT
Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
[TBL] [Abstract][Full Text] [Related]
15. Application of Simultaneous
Huang Z; Li X; Wang Z; Meng N; Fu F; Han H; Li D; Bai Y; Wei W; Fang T; Feng P; Yuan J; Yang Y; Wang M
J Magn Reson Imaging; 2022 Jul; 56(1):63-74. PubMed ID: 34888990
[TBL] [Abstract][Full Text] [Related]
16. Relationship between
Du S; Sun H; Gao S; Xin J; Lu Z; Chen Z; Pan S; Guo Q
Clin Radiol; 2019 Mar; 74(3):178-186. PubMed ID: 30545566
[TBL] [Abstract][Full Text] [Related]
17. Primary tumor standardized uptake value (SUVmax) measured on
Hui Z; Wei F; Ren H; Xu W; Ren X
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919
[TBL] [Abstract][Full Text] [Related]
18. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
Satoh Y; Onishi H; Nambu A; Araki T
Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640
[TBL] [Abstract][Full Text] [Related]
19. The increment in standardized uptake value determined using dual-phase 18F-FDG PET is a promising prognostic factor in non-small-cell lung cancer.
Chen HH; Lee BF; Su WC; Lai YH; Chen HY; Guo HR; Yao WJ; Chiu NT
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1478-85. PubMed ID: 23744342
[TBL] [Abstract][Full Text] [Related]
20. The utility of
Kitajima K; Kawanaka Y; Komoto H; Minami T; Yokoi T; Kuribayashi K; Kijima T; Nakamura A; Hashimoto M; Kondo N; Hasegawa S; Yamakado K
Hell J Nucl Med; 2021; 24(3):186-198. PubMed ID: 34901959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]